ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Sudarshan Pharma Industries Ltd submitted its quarterly shareholding pattern under Regulation 31. This periodic disclosure provides details on promoter and public equity ownership.
Sudarshan Pharma Industries submitted its Annual Secretarial Compliance Report for FY2026. The report by a practicing company secretary confirms overall regulatory compliance with no material penalties.
Sudarshan Pharma Industries revised its FCCB conversion rate to Rs.96.8441 per USD following updated RBI rates. The USD 20 million issue reflects a Rs.193.69 Crore value.
Sudarshan Pharma Industries Ltd submitted certificates under Regulation 74(5) of SEBI Regulations for the quarter ended March 31, 2026. The certificates from KFin Technologies confirm compliance regarding the dematerialization and rematerialization of securities.